VSTM - Financial Reports List - Verastem, Inc. - IntrinsicAlpha

Verastem, Inc. VSTM

Healthcare - Biotechnology - NASDAQ - US

$ 6.885

8.19 %

$ 355 M

Market Cap

-1.7

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-135.86%	-1.45%
Annual Report	FY	10-K	2024-12-31	0.00%	-49.53%	-24.84%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-19.81%	-73.78%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	66.00%	9.93%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-163.46%	-45.05%
Quarterly Report	Q4	8-K	2023-12-31	-95.61%	-62.71%	-84.85%
Annual Report	FY	10-K	2023-12-31	0.00%	-18.31%	-26.25%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-10.51%	-20.33%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-10.61%	5.19%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	24.26%	-13.92%

1